22 6月 2022 by admin in UncategorizedComments Dr. Brahm Segal appointed to NextCure Scientific Advisory Board; NextCure and Roswell Park Shared Nonclinical Data on the Impact of NC410 Blockade on Neutrophil-mediated T Cell Suppression at the 24th Translational Research Cancer Centers Consortium Annua
21 6月 2022 by admin in UncategorizedComments Arcellx Announces Closing Of Upsized Public Offering Of Common Stock And Underwriters’ Full Exercise Of Option To Purchase Additional Shares
21 6月 2022 by admin in UncategorizedComments Arcellx Announces Appointment Of Maryam Abdul-Kareem As General Counsel
15 6月 2022 by admin in UncategorizedComments Arcellx Announces Upsizing And Pricing Of Follow-On Public Offering
09 6月 2022 by admin in UncategorizedComments Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance
